Revolution Medicines, Inc. (1RVMD)
MTA
183.50
+4.80 (+2.69%)
Closed
Aug 25, 2026
Day's Range
182.05183.50
52 wk Range
46.20189.35
Financial Statements - 1RVMD - Revolution Medicines, Inc.
Revenue
0
Net Income
-1.13B▼ 88.5%
EBITDA
-1.07B▼ 57.6%
Free Cash Flow
-913.73M▼ 60.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 0 | 0 |
| Cost of Goods | - | - |
| Gross Profit | - | - |
 Operating Expense | - | - |
| Operating Income | -1.18B | -689.52M |
| Non-Operating Interest | - | - |
| Other Income Expense | -15.39M | 1.79M |
| Pre Tax Income | -1.13B | -600.84M |
| Income Tax | 0 | -753K |
| Net Income | -1.13B | -600.09M |
| EPS Basic | -5.95 | -3.58 |
| EPS Diluted | -5.95 | -3.58 |
| Basic Shares Outstanding | 190.12M | 167.73M |
| Diluted Shares Outstanding | 190.12M | 167.73M |
| Ebit | -1.10B | -689.52M |
| Ebitda | -1.07B | -682.02M |
| Net Income Continuous Operations | -1.13B | -600.09M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
